Andreas I. Jensen
Papers
2
Total Citations
34
H-Index
2
About
Andreas I. Jensen is a leading figure in molecular imaging and nanomedicine, whose work bridges the critical gap between high-resolution diagnostics and targeted therapy. His research centers on the development of novel radiolabeled probes and smart biomaterials for multimodal imaging and image-guided interventions. A key contribution is the creation of an [¹⁸F]-fluorocholesteryl ether probe for PET imaging of liposomes, enabling non-invasive tracking of drug delivery vehicles. This work, detailed in a 2012 paper, required pioneering automated radiosynthesis techniques to achieve clinically relevant yields. More recently, Jensen has advanced the field of theranostics by engineering multimodal soft tissue markers. As described in his 2020 highly cited work, these markers are designed to translate the sensitivity of diagnostic imaging—such as MRI or PET—directly into the operating room, allowing surgeons to precisely identify and resect small lesions that would otherwise be invisible. With each of his seminal papers garnering 17 citations, Jensen’s impact lies in creating tangible tools that enhance the precision of both diagnosis and therapy, directly improving patient outcomes in oncology and interventional medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2